These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22399511)

  • 1. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
    Gennari L; Merlotti D; Valenti R; Ceccarelli E; Ruvio M; Pietrini MG; Capodarca C; Franci MB; Campagna MS; Calabrò A; Cataldo D; Stolakis K; Dotta F; Nuti R
    J Clin Endocrinol Metab; 2012 May; 97(5):1737-44. PubMed ID: 22399511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
    Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
    Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
    Grethen E; Hill KM; Jones R; Cacucci BM; Gupta CE; Acton A; Considine RV; Peacock M
    J Clin Endocrinol Metab; 2012 May; 97(5):1655-62. PubMed ID: 22362819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preeclampsia - a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia.
    Wild J; Pateisky P; Küssel L; Huf W; Ott J; Haslinger P; Knöfler M; Zeisler H
    Hypertens Pregnancy; 2014 Aug; 33(3):333-40. PubMed ID: 24568269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
    Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults.
    Napoli N; Strollo R; Defeudis G; Leto G; Moretti C; Zampetti S; D'Onofrio L; Campagna G; Palermo A; Greto V; Manfrini S; Hawa MI; Leslie RD; Pozzilli P; Buzzetti R;
    J Clin Endocrinol Metab; 2018 May; 103(5):1921-1928. PubMed ID: 29506222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls.
    van Lierop AH; Witteveen JE; Hamdy NA; Papapoulos SE
    Eur J Endocrinol; 2010 Nov; 163(5):833-7. PubMed ID: 20817762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial.
    Strollo R; Soare A; Manon Khazrai Y; Di Mauro A; Palermo A; Del Toro R; Fallucca S; Giovanna Belluomo M; Dugo L; Pianesi M; Pozzilli P; Napoli N
    Endocrine; 2017 Jun; 56(3):667-674. PubMed ID: 27888435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating sclerostin in disorders of parathyroid gland function.
    Costa AG; Cremers S; Rubin MR; McMahon DJ; Sliney J; Lazaretti-Castro M; Silverberg SJ; Bilezikian JP
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3804-10. PubMed ID: 21937621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus.
    Catalano A; Pintaudi B; Morabito N; Di Vieste G; Giunta L; Bruno ML; Cucinotta D; Lasco A; Di Benedetto A
    Eur J Endocrinol; 2014 Sep; 171(3):293-300. PubMed ID: 24891138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
    García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.
    Wanby P; Nobin R; Von SP; Brudin L; Carlsson M
    J Endocrinol Invest; 2016 Aug; 39(8):855-63. PubMed ID: 26850415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
    Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
    Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.
    Evenepoel P; Claes K; Viaene L; Bammens B; Meijers B; Naesens M; Sprangers B; Kuypers D
    Transplantation; 2016 Oct; 100(10):2188-93. PubMed ID: 27379556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
    Zhou YJ; Li A; Song YL; Zhou H; Li Y; Tang YS
    Chin Med Sci J; 2013 Sep; 28(3):135-9. PubMed ID: 24074614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.
    Gaudio A; Pennisi P; Bratengeier C; Torrisi V; Lindner B; Mangiafico RA; Pulvirenti I; Hawa G; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2010 May; 95(5):2248-53. PubMed ID: 20305005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.